Sodium Chondroitin Sulfate
Table of Contents of the Leaflet:
The active substance of Cartexan, sodium chondroitin sulfate, is a substance that occurs naturally in the human body. It is one of the structural elements of joint cartilage.
Cartexan is used for the symptomatic treatment of osteoarthritis of the knee and hip joints. The drug is characterized by a slow onset of action, which occurs within 6 to 8 weeks, therefore, for the treatment of acute and short-term pain, it is recommended to use other medications. The effects of treatment usually last for 2 to 3 months after discontinuation of treatment.
If there is no improvement or the patient feels worse, they should consult a doctor.
Before starting treatment with Cartexan, the patient should discuss it with their doctor or pharmacist.
Cartexan is not recommended for use in children.
The patient should inform their doctor or pharmacist about all medications they are currently taking or have recently taken, as well as any medications they plan to take. This is especially important for medications that affect blood clotting (such as warfarin, acetylsalicylic acid, dipyridamole, or clopidogrel).
If the patient is taking warfarin, after starting or stopping Cartexan, the doctor may order more frequent INR checks.
Cartexan can be taken before, during, or after meals. If the patient is prone to stomach problems, the medication should be taken after a meal.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before taking this medication.
There is no data on the use of Cartexan during pregnancy or breastfeeding, and therefore, the medication should not be taken during pregnancy or breastfeeding.
It has not been shown that Cartexan affects the ability to drive or operate machinery.
This medication should always be taken as directed by the doctor. In case of doubts, the patient should consult their doctor or pharmacist.
The capsules should not be chewed, they should be swallowed whole, with a sufficient amount of liquid (e.g., a glass of water).
The recommended dose is 800 mg, i.e., 2 capsules in one daily dose taken for three months.
In more severe cases, the recommended dose is 1200 mg, i.e., 3 capsules per day for the first 4 to 6 weeks of treatment, and then 800 mg in one daily dose until the end of the three-month treatment period. The daily dose of 1200 mg can be taken once or divided into three doses, i.e., 1 capsule three times a day.
Treatment consists of repeated periods of three-month treatment with two-month breaks without taking the medication.
Cartexan is not recommended for children.
One report of unintentional or intentional overdose without consequences for the patient (no vomiting, nausea, or changes in blood electrolyte levels occurred) has been received. Based on studies, no harmful effects or symptoms are expected. In case of overdose, the patient should always contact the Toxicological Information Center (tel. 607 218 174).
No special effects are expected. The patient should not take a double dose to make up for the missed dose, they should continue treatment by taking the normal dose the next day.
No special effects are expected.
In case of any further doubts about the use of this medication, the patient should consult their doctor or pharmacist.
Like all medications, Cartexan can cause side effects, although not everybody gets them.
Gastrointestinal Disorders: Gastrointestinal disorders (such as upper abdominal pain, nausea, or diarrhea).
Skin and Subcutaneous Tissue Disorders:Redness, papular rash, irritating dermatitis.
Skin and Subcutaneous Tissue Disorders:eczema, itching, urticaria.
General Disorders:Edema.
If any side effects occur, including any not listed in this leaflet, the patient should inform their doctor or pharmacist. Side effects can be reported directly to the national reporting system:
Department of Monitoring of Adverse Reactions to Medicinal Products, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C
02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help to gather more information on the safety of this medication.
The medication should be stored out of sight and reach of children.
Do not store above 30°C. Store in the original packaging to protect from moisture.
Do not use this medication after the expiry date stated on the carton and blister pack after "Expiry Date:". The expiry date refers to the last day of the month stated.
Medications should not be disposed of via wastewater or household waste containers. The patient should ask their pharmacist how to dispose of medications that are no longer needed. This will help protect the environment.
Cartexan capsules are available in packs of 24, 60, and 180 capsules. The bulk pack contains 180 (3 packs of 60) capsules.
Not all pack sizes may be marketed.
REIG JOFRE Sp. z o.o.
ul. Ostródzka 74N
03-289 Warsaw
Poland
NOUCOR HEALTH, S.A.
Avda. Camí Reial, 51-57.
08184 Palau-Solità i Plegamans. Barcelona
Spain
Austria, Finland, Hungary, and Poland - Cartexan
Czech Republic - Condrodin
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.